ArticleDiabetes & vascular disease research

Impact of glucagon like peptide-1 receptor agonist and sodium glucose cotransporter 2 inhibitors on type 2 diabetes patients with renal impairment.

Takeyuki Hiramatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.